The US Food and Drug Administration (FDA) has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System. The solution enables real-time localisation ...
MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) -- Elucent Medical (“Elucent”), a leading innovator in the field of guided surgical technologies, announced today that the U.S. Food and Drug Administration ...
Elucent Medical's flagship product EnVisio System utilizes a spatial field generator measuring continuous data points across multiple planes to display exact 3D positioning of the SmartClip marker and ...